According to WiseGuy Reports, the Injectable Sealants Market was valued at USD 5.15 billion in 2024 and reached USD 5.42 billion in 2025. The market is projected to reach USD 9.0 billion by 2035, registering a CAGR of 5.2% during 2026–2035. Rising demand for minimally invasive procedures, increasing surgical volumes, growing wound care requirements, orthopedic procedures, an aging population, and advances in sealant technologies are supporting expansion. Major companies profiled include Baxter International, Medtronic, W. L. Gore & Associates, AptarGroup, Cardinal Health, Becton Dickinson, Abbott Laboratories, Terumo Corporation, Stryker Corporation, Smith & Nephew, B. Braun Melsungen, and Johnson & Johnson.

Market Overview

Injectable sealants are medical products designed to support tissue adhesion, wound closure, bone adhesion, and other surgical applications. Their ability to be delivered directly to targeted areas makes them useful in procedures where controlled application and effective sealing are required.

The market encompasses biologics, synthetic polymers, and adhesive formulations available in liquid, gel, and paste forms. Hospitals, clinics, and ambulatory surgical centers represent the principal end-use settings.

Growing preference for less invasive treatment approaches is creating favorable conditions for injectable sealants. Healthcare providers are increasingly seeking technologies that can support surgical efficiency, tissue management, and recovery while addressing specific procedural requirements.

Market Size Reached in 2025

The market reached USD 5.42 billion in 2025, increasing from USD 5.15 billion in 2024. The growth reflects continued demand for surgical products across wound care, tissue adhesion, orthopedic procedures, and dental applications.

The rising number of surgical procedures worldwide is creating a broad customer base for injectable sealant technologies. As healthcare systems expand access to specialized treatments, demand for products that support wound closure and tissue management can increase.

An aging population is also contributing to healthcare demand. Older patients are more likely to require surgical interventions and wound care, creating additional opportunities for medical technologies that can support clinical procedures.

Expected Market Size by 2035

The Injectable Sealants Market is forecast to reach USD 9.0 billion by 2035. Growth is expected to be supported by continued investment in healthcare infrastructure, increasing surgical activity, and improvements in product performance.

Orthopedic procedures represent an important opportunity. Injectable materials designed for bone adhesion and related applications can support procedures where controlled tissue or bone interaction is required.

Wound care is another expanding application area. Healthcare providers are increasingly focused on efficient wound management, particularly in settings where rapid and controlled closure can contribute to patient care.

Emerging healthcare markets are also expected to provide opportunities as hospitals and surgical facilities expand their capabilities.

Market CAGR

The market is projected to expand at a CAGR of 5.2% between 2026 and 2035. This growth reflects increasing procedure volumes and continued innovation in medical sealant formulations.

Product development is increasingly focused on characteristics such as biocompatibility, ease of application, adhesion performance, and controlled handling. Improvements in formulation technologies may help manufacturers address increasingly specialized clinical requirements.

Key Growth Drivers

Minimally invasive surgery is one of the leading market drivers. Surgeons increasingly require materials that can be applied accurately while supporting tissue management without relying exclusively on traditional closure methods.

The global increase in surgical procedures is another important factor. Growth in hospitals, ambulatory surgical centers, and specialized clinics expands the potential use of injectable sealants across multiple procedure types.

Wound care demand is also contributing to market expansion. Advanced sealant products can provide healthcare professionals with additional options for managing wounds and supporting closure.

Technological advancement remains central to industry development. Manufacturers are working on improved formulations and delivery characteristics to enhance usability and clinical performance.

Emerging Market Trends

Biologically derived sealants are receiving greater attention as healthcare providers and manufacturers focus on compatibility with human tissue. Synthetic polymers remain important because of their ability to provide controlled material characteristics and application flexibility.

The development of gel and paste formulations is also creating opportunities for applications requiring precise placement. Liquid formulations provide another option where spreading or controlled delivery is desirable.

Outpatient healthcare is an additional trend influencing the market. As more procedures are performed in ambulatory settings, compact and easy-to-administer medical products can become increasingly valuable.

Competitive Landscape

The competitive landscape includes pharmaceutical companies, medical-device manufacturers, healthcare suppliers, and organizations specializing in wound-care technologies. Companies compete through product performance, formulation development, clinical applications, regulatory capabilities, and geographic reach.

Key companies profiled include Baxter International, Medtronic, W. L. Gore & Associates, AptarGroup, AdvaCare, MediWound, Cardinal Health, Becton Dickinson, Abbott Laboratories, Terumo Corporation, Stryker Corporation, Smith & Nephew, B. Braun Melsungen, Sealed Air Corporation, and Johnson & Johnson.

Market participants are expected to focus on advanced formulations, broader clinical applications, improved delivery systems, and expansion into emerging healthcare markets as demand continues to develop through 2035.